scispace - formally typeset
R

Robert S. Janssen

Researcher at Centers for Disease Control and Prevention

Publications -  107
Citations -  15619

Robert S. Janssen is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 52, co-authored 97 publications receiving 15270 citations. Previous affiliations of Robert S. Janssen include Government of the United States of America.

Papers
More filters
Journal Article

Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings

TL;DR: The objectives of these recommendations are to increase HIV screening of patients, including pregnant women, in health-care settings; foster earlier detection of HIV infection; identify and counsel persons with unrecognized HIV infection and link them to clinical and prevention services; and further reduce perinatal transmission of HIV in the United States.
Journal ArticleDOI

Estimation of HIV Incidence in the United States

TL;DR: This study provides the first direct estimates of HIV incidence in the United States using laboratory technologies previously implemented only in clinic-based settings and indicated that HIV incidence increased in the mid-1990s, then slightly declined after 1999 and has been stable thereafter.
Journal Article

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

TL;DR: This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.
Journal ArticleDOI

New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes

TL;DR: The sensitive/less sensitive testing strategy provides accurate diagnosis of early HIV-1 infection, provides accurate estimates of HIV- 1 incidence, can facilitate clinical studies of earlyAIDS, and provides information on HIV-2 infection duration for care planning.